Vaccination is a process or technique of improving the immunity of an individual against any specific infectious or chronic disease. So far, vaccination has saved a large number of lives including children, adults and animals, thus furnishing them with a relatively better and healthier quality of life saving and immunizing them against various infectious microorganisms such as bacteria and virus. This is considered to be one of the most crucial reasons behind the rapid growth of global pediatrics vaccines market over the forecast period. In addition, vaccines are able to stimulate the immune systems of human body in order to protect the concerned individual from subsequent diseases or infections. Vaccines are usually categorized into two main target markets such as pediatric and adult. Pediatric vaccines thus are most commonly employed for proper and efficient immunization of toddlers and children as well as adolescents against several infections such as diphtheria, diseases, hepatitis, influenza, meningococcal diseases and pneumococcal diseases among others.
Rising non-government and government funding associated with the development of vaccines is one of the key factors driving the overall pediatric vaccine market over the forecast period. In addition, advancements in technology such as therapeutic and adjuvant vaccines are further anticipated to fuel the growth of global pediatric vaccines market over the forecast period. Additionally, increasing investments by various players in the market as well as key manufacturers of pediatric vaccines is further increasing the growth of global market. Moreover, increasing inclination of organizations as well as government bodies on immunization schedule prescribed by doctors for the adolescents as well as rising awareness programs led by healthcare organizations such as WHO, UNICEF and others are further projected to bolster the growth of global pediatric vaccines market.
The global pediatric vaccines market can be segmented on the basis of technology, diseases and region. On the basis of technology, the global pediatric vaccines market can be segmented into live attenuated vaccines, recombinant vaccines, inactivated and subunit vaccines, conjugate vaccines, toxoid vaccines. On the basis of diseases, the global pediatric vaccines market can be segmented into diphtheria, hepatitis B, hepatitis A, measles, mumps, polio, rubella, tetanus, varicella, pertussis, influenza and others. On the basis of region, the global pediatric vaccines market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific. The robust demand in Asia-Pacific is expected to be the major driving factor for the growth of pediatrics vaccines market. China is anticipated to account for the largest share and lead the overall demand for pediatrics vaccines owing to the increasing industrial production over the last few years. The markets in other developing countries such as Brazil, Russia, Poland, Indonesia, New Zealand, Argentina and India among others are also anticipated to grow rapidly throughout the forecast period.
Major players operating in the global pediatrics vaccines market are focusing on some key market strategies such as mergers and acquisitions to keep hold in the ever competitive market. Moreover, they are concentrating on collaborating with local players to increase their market reach as well as strengthen their goodwill in the global market. Some of the major players in global pediatrics vaccines system market include Sanofi, Novartis AG., Amgen Inc., Abbott Laboratories, AstraZeneca Plc, Shire Pharmaceuticals Group Plc, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Merck & Co. Inc, Eli Lilly and Company, GlaxoSmithKline, Genentech Inc., Shire Pharmaceuticals Group Plc, Actelion Pharmaceuticals Ltd, Shire Pharmaceuticals Group Plc and Abbott Laboratories among others.
Market by Technology
· Live Attenuated Vaccines
· Recombinant Vaccines
· Inactivated and Subunit Vaccines
· Conjugate Vaccines
· Toxoid Vaccines
Market by Disease
· Hepatitis B
· Hepatitis A
· Others (Tetanus, Varicella, Pertussis, Rubella, Mumps, etc.)
Market by Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Introduction ECG Equipment and Management Systems is a gadget which records the heart exercises through electric signals and are enhanced on the ECG screen. ECG Equipment and Management Systems are utilized to analyze sorts of heart illnesses and arrhythmias in an individual's body in this manner help the suitable treatment. The ECG test is noninvasive and effortless method and decides irregularity designs
Introduction Ear, nose and throat are some of the most vital parts of the human body. It is very important to keep the functions of these parts properly. There are many factors that affect the normal functioning of these organs such as sinusitis and aging. ENT, a prominent amongst the most vital parts of medical science is basically focusing on diagnosis and treatment of the different issues related with e
Introduction The global macular degeneration treatment Market is estimated to value US$ 11.4 Billion by 2026 and the market is projected to showcase 6.6% CAGR during the forecast period. The macular degeneration treatment market is driven by surge in healthcare spending and improved in healthcare infrastructure. Market D
Introduction The world-wide Anticoagulants market is expected to garner USD 39 billion by 2026 and the market is expected to register CAGR growth over 7.9% during the next eight years. Market Dynamics Growing need for controlling the diseases such as kidney diseases and cardi
Introduction The global Gynecological Devices market was valued at $9.4 billion in 2018 and is anticipated to grow at a CAGR of 7.9% during the forecast period. Gynecological devices include instruments and devices used for the treatment of diseases related to the female reproductive system. These devices include surgical devices, handheld instruments, diagnostic i
Introduction The international transfusion technology market’s worth is likely to touch USD 7,138 Million by 2026 and the market is expected to project a CAGR of 5.4% during the upcoming years. Market Dynamics The worldwide transfusion technology market is described by